Equivalent efficacies of reverse hybrid and concomitant therapies in first‐line treatment of Helicobacter pylori infection-Reference-Cited by-同舟云学术

Equivalent efficacies of reverse hybrid and concomitant therapies in first‐line treatment of Helicobacter pylori infection

Published:2020-03-31 Issue:10 Volume:35 Page:1731-1737
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Hsu Ping‐I¹^ORCID,Tsay Feng‐Woei²,Kao John Y³,Peng Nan‐Jing⁴,Tsai Kuo‐Wang⁵,Tsai Tzung‐Jiun²,Kuo Chao‐Hung⁶,Kao Sung‐Shuo²,Wang Huay‐Min²,Chen Yan‐Hua²,Shie Chang‐Bih¹,Wu Deng‐Chyang⁷,

Affiliation:

1. Division of Gastroenterology and Hepatology, Department of Internal Medicine An Nan Hospital, China Medical University Tainan Taiwan

2. Department of Internal Medicine Kaohsiung Veterans General Hospital and National Yang‐Ming University Kaohsiung Taiwan

3. Department of Internal Medicine, Division of Gastroenterology Michigan Medicine, University of Michigan Ann Arbor Michigan USA

4. Department of Nuclear Medicine Kaohsiung Veterans General Hospital and National Yang‐Ming University Kaohsiung Taiwan

5. Department of Medical Education and Research Kaohsiung Veterans General Hospital Kaohsiung Taiwan

6. Division of Gastroenterology, Department of Internal Medicine Kaohsiung Municipal Siaogang Hospital Kaohsiung Taiwan

7. Division of Gastroenterology, Department of Internal Medicine Kaohsiung Municipal Siaogang Hospital Kaohsiung Taiwan

Funder

Kaohsiung Veterans General Hospital

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.15034

Reference29 articles.

1. H pylori antibiotic resistance: prevalence, importance, and advances in testing

2. Empiric Quadruple vs. Triple Therapy for Primary Treatment of Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Efficacy and Tolerability

3. The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis

4. Meta-analysis: Four-Drug, Three-Antibiotic, Non-bismuth-Containing “Concomitant Therapy” Versus Triple Therapy forHelicobacter pyloriEradication

5. Modified Sequential Helicobacter pylori Therapy: Proton Pump Inhibitor and Amoxicillin for 14 Days with Clarithromycin and Metronidazole added as a Quadruple (Hybrid) Therapy for the Final 7 Days

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Independent risk factors predicting eradication failure of standard bismuth quadruple therapy for the first‐line treatment of Helicobacter pylori infection in Taiwan;Advances in Digestive Medicine;2024-04-11

2. Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial;American Journal of Gastroenterology;2023-03-20

3. Non-inferiority of reverse hybrid regimen versus standard concomitant regimen for H. pylori eradication in a randomized-controlled trial;CASP J INTERN MED;2023

4. Cut-off value of clarithromycin resistance in the treatment ofHelicobacter pyloriinfection: how low is low?;Gut;2022-12-30

5. Effect of metronidazole resistance on Helicobacter pylori eradication regimens;Journal of Digestive Diseases;2022-10